[原著(英文)]
Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successfdl cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 108: 346-353, 2006.
Takeuchi S, Akita T, Takagishi Y, Watanabe E, Sasano C, Honjo H, Kodama I. Disorganization of gap junction distribution in dilated atrial of patients with chronic atrial fibrillation. Circ J 70: 575-582, 2006.
Ito Y, Kurata M, Suzuki K, Hamajima N, Hishida H, Aoki K. Cardiovascdlar disease mortaddty and serum carotenoid levels: a Japanese popdlation-based follow-up study. J Epidemiol 16: 154-160, 2006.
Waseda K, Ozaki Y, Takashima H, Ako J, Yasukawa T, Ismail TF, Hishida H, Ito T. Impact of angiotensin II receptor blockers on the progression and regression of coronary atherosclerosis -An Intravascdlar dltrasound Study – . Circ J 70: 1111-1115, 2006.
Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune T, Saikawa T, Sakurai M, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E; on behalf of the J-RHYTHM II Investigators. Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertension- The J-RHYTHM II study design for the investigation of upstream therapy for atrial fibrillation- Circ J 70: 1318-1321, 2006.
Morimoto S, Kato S, Hiramitsu S, Uemura A, Ohtsuki M, Kato Y, Sugiura A, Miyagishima K, Yoshida Y, Hishida H. Role of myocardial interstitial edema in conduction disturbances in acute myocarditis. Heart Vessels 21: 356-360, 2006.
Hirashiki A, Izawa H, Somura F, Obata K, Kato T, Nishizawa T, Yamada A, Asano H, Ohshima S, Noda A, Iino S, Nagata K, Okumura K, Murohara T, Yokota M. Prognostic value of pacing- induced mechanical alternans in patients with mild- to- moderate idiopathic dilated cardiomyopathy in sinus rhythm. J Am Coll Cardiol 47: 1382-1389, 2006.
Ichihara S, Obata K, Yamada Y, Nagata K, Noda A, Ichihara G, Yamada A, Kato T, Izawa H, Murohara T, Yokota M. Attenuation of cardiac dysfunction by a PPAR- alfa agonist is associated with down- regdlation of redox- regurlated transcription factors. J Mol Cell Cardiol 41: 318-329, 2006.
Ito Y, Suzuki K, Ishii J, Hishida H, Tamakoshi A, Hamajima N, Aoki K. A popdlation-based follow-up study on mortaddty from cancer or cardiovascdlar disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants. Asian Pac J Cancer Prev 7: 533-546, 2006.
Miyauchi K, Kimura T, Morimoto T, Nakagawa Y, Yamagishi M, Ozaki Y, Hiro T, Daida H, Matsuzaki M. Japan assessment of pitabastatin and atrovastatin in acute coronary syndrome (Japan-ACS); rationale and design. Circ J 70:1624-1628, 2006.
Yamada S, Yakabe J, Ishii J, Imaizumi H, Maruyama S. New high mobiddty group box 1 assay system. Cddn Chim Acta 372: 173-178, 2006.
[症例報告(英文)]
Morimoto S, Sugiura A, Iwase M, Kubo N, Hiramitsu S, Uemura A, Ohtsuki M, Kato S, Kato Y, Hishida H. Reddef of left ventricdlar outflow obstruction by cibenzoddne in a patient with Fabry’s disease -A Case Report. Angiology 57(2): 241-245, 2006.
Hiramitsu S, Morimoto S, Kato S, Uemura A, Ohtsuki M, Kato Y, Miyagishima K, Mori N, Yoda R, Mori K, Kimura H, Yamamoto N, Hishida H. Cddnical course of myocarditis through the acute, fdlminant and fatal chronic stages. Circ J 70(8): 1086-1090, 2006